Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972844321> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1972844321 abstract "Introduction: Bone metastases are a major cause of morbidity for men with prostate cancer (PCa). Although PCa cells produce osteoblastic metastases, there is an initial and ongoing osteoclast (OC)-mediated osteolytic phase that is essential for PCa bone metastases. OC-mediated bone resorption is dependent upon OC secretion of bone acid phosphatase. PCa cells in bone secrete high levels of prostatic acid phosphatase (PAP) which differs from BAP in that PAP enzymatic activity is inhibited by tartrate and glyceric acid, whereas BAP is tartrate-resistant. Hypothesis: PAP secreted by human PCa cells in bone acts similarly to OC-derived bone acid phosphatase to degrade bone matrix and enhance PCa bone-targeting and growth in bone. We developed new compounds consisting of glyceric acid or tartrate (known PAP inhibitors) conjugated to a bisphosphonate to inhibit PCa bone metastases. Methods: PCa bone metastases derived from 7 patients were immunostained for androgen receptor (AR), prostate specific antigen (PSA) and PAP expression. The VCaP human PCa cell line derived from a vertebral metastases was inoculated intratibially into SCID mice (n=8) and bone lesions immunostained for AR, PSA, and PAP. Co-cultures of MC3T3 osteoblasts and VCaP cells were treated with tartrate and the effects on cell number, PAP and bone alkaline phosphatase (ALP) secretion measured by ELISA. Glyceric Acid and Tartaric acid were then conjugated with alendronate and the effects of these new conjugates on PAP enzymatic activity were compared to alendronate alone and tartrate alone. Results: Human PCa bone lesions (7/7) had strongly positive expression of PAP, with little AR or PSA expression. 8/8 SCID mice inoculated with VCaP cells intratibially developed osteoblastic VCaP lesions and these similarly had high PAP expression and no PSA expression. Tartrate addition to co-cultures of VCaP and MC3T3 osteoblasts reduced MC3T3 cell numbers and ALP secretion. In vitro testing of the conjugates revealed that the glyceric acid-alendronate conjugate inhibited PAP enzymatic activity but the tartrate-alendronate conjugate and alendronate alone had no significant inhibitory activity. Discussion: We have evidence that PAP secretion by PCa cells enhances their bone metastatic ability. We have developed new bone-targeting agents that consist of alendronate conjugated to PAP-inhibitory small molecules for further development as oral agents to prevent and treat PCa bone metastases. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-375." @default.
- W1972844321 created "2016-06-24" @default.
- W1972844321 creator A5010523023 @default.
- W1972844321 creator A5011662857 @default.
- W1972844321 creator A5034515596 @default.
- W1972844321 creator A5038405249 @default.
- W1972844321 creator A5075926965 @default.
- W1972844321 creator A5085576609 @default.
- W1972844321 date "2010-04-15" @default.
- W1972844321 modified "2023-09-25" @default.
- W1972844321 title "Abstract LB-375: Development of new compounds specifically targeting prostate cancer bone metastases" @default.
- W1972844321 doi "https://doi.org/10.1158/1538-7445.am10-lb-375" @default.
- W1972844321 hasPublicationYear "2010" @default.
- W1972844321 type Work @default.
- W1972844321 sameAs 1972844321 @default.
- W1972844321 citedByCount "0" @default.
- W1972844321 crossrefType "proceedings-article" @default.
- W1972844321 hasAuthorship W1972844321A5010523023 @default.
- W1972844321 hasAuthorship W1972844321A5011662857 @default.
- W1972844321 hasAuthorship W1972844321A5034515596 @default.
- W1972844321 hasAuthorship W1972844321A5038405249 @default.
- W1972844321 hasAuthorship W1972844321A5075926965 @default.
- W1972844321 hasAuthorship W1972844321A5085576609 @default.
- W1972844321 hasConcept C121608353 @default.
- W1972844321 hasConcept C126322002 @default.
- W1972844321 hasConcept C134018914 @default.
- W1972844321 hasConcept C160160445 @default.
- W1972844321 hasConcept C170033053 @default.
- W1972844321 hasConcept C170493617 @default.
- W1972844321 hasConcept C180675623 @default.
- W1972844321 hasConcept C181199279 @default.
- W1972844321 hasConcept C185592680 @default.
- W1972844321 hasConcept C21547065 @default.
- W1972844321 hasConcept C2776033226 @default.
- W1972844321 hasConcept C2776490512 @default.
- W1972844321 hasConcept C2776541429 @default.
- W1972844321 hasConcept C2777251235 @default.
- W1972844321 hasConcept C2777783956 @default.
- W1972844321 hasConcept C2780192828 @default.
- W1972844321 hasConcept C502942594 @default.
- W1972844321 hasConcept C55493867 @default.
- W1972844321 hasConcept C673006 @default.
- W1972844321 hasConcept C71924100 @default.
- W1972844321 hasConceptScore W1972844321C121608353 @default.
- W1972844321 hasConceptScore W1972844321C126322002 @default.
- W1972844321 hasConceptScore W1972844321C134018914 @default.
- W1972844321 hasConceptScore W1972844321C160160445 @default.
- W1972844321 hasConceptScore W1972844321C170033053 @default.
- W1972844321 hasConceptScore W1972844321C170493617 @default.
- W1972844321 hasConceptScore W1972844321C180675623 @default.
- W1972844321 hasConceptScore W1972844321C181199279 @default.
- W1972844321 hasConceptScore W1972844321C185592680 @default.
- W1972844321 hasConceptScore W1972844321C21547065 @default.
- W1972844321 hasConceptScore W1972844321C2776033226 @default.
- W1972844321 hasConceptScore W1972844321C2776490512 @default.
- W1972844321 hasConceptScore W1972844321C2776541429 @default.
- W1972844321 hasConceptScore W1972844321C2777251235 @default.
- W1972844321 hasConceptScore W1972844321C2777783956 @default.
- W1972844321 hasConceptScore W1972844321C2780192828 @default.
- W1972844321 hasConceptScore W1972844321C502942594 @default.
- W1972844321 hasConceptScore W1972844321C55493867 @default.
- W1972844321 hasConceptScore W1972844321C673006 @default.
- W1972844321 hasConceptScore W1972844321C71924100 @default.
- W1972844321 hasLocation W19728443211 @default.
- W1972844321 hasOpenAccess W1972844321 @default.
- W1972844321 hasPrimaryLocation W19728443211 @default.
- W1972844321 hasRelatedWork W148014305 @default.
- W1972844321 hasRelatedWork W1489941763 @default.
- W1972844321 hasRelatedWork W1604082007 @default.
- W1972844321 hasRelatedWork W1989526399 @default.
- W1972844321 hasRelatedWork W1995922001 @default.
- W1972844321 hasRelatedWork W2037379514 @default.
- W1972844321 hasRelatedWork W2082142002 @default.
- W1972844321 hasRelatedWork W2142365214 @default.
- W1972844321 hasRelatedWork W2189967629 @default.
- W1972844321 hasRelatedWork W2246723471 @default.
- W1972844321 hasRelatedWork W2318404763 @default.
- W1972844321 hasRelatedWork W2323366308 @default.
- W1972844321 hasRelatedWork W2402050656 @default.
- W1972844321 hasRelatedWork W2409840503 @default.
- W1972844321 hasRelatedWork W2490409900 @default.
- W1972844321 hasRelatedWork W2564443150 @default.
- W1972844321 hasRelatedWork W2590846069 @default.
- W1972844321 hasRelatedWork W2593904759 @default.
- W1972844321 hasRelatedWork W2887694084 @default.
- W1972844321 hasRelatedWork W290205020 @default.
- W1972844321 isParatext "false" @default.
- W1972844321 isRetracted "false" @default.
- W1972844321 magId "1972844321" @default.
- W1972844321 workType "article" @default.